Combotope Therapeutics
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$580,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Combotope Therapeutics is a Danish biotechnology company that pioneers the discovery of highly tumor-selective antibodies by targeting cancer-specific glycan-protein epitopes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combotope Therapeutics Comparables
Compare Combotope Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 88% | |
| TegMine Therapeutics | 85% | |
| Palleon Pharmaceuticals | 77% | |
Combotope Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 10, 2026 |
Combotope Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$580K raised from BioInnovation Institute
Combotope Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Combotope Therapeutics's valuation, stock price, and market status.